tiprankstipranks
Vor Biopharma (VOR)
NASDAQ:VOR
US Market
VOR
Vor Biopharma
RESEARCH TOOLSreports
Want to see VOR full AI Analyst Report?

Vor Biopharma (VOR) Income Statement

960 Followers

Vor Biopharma Income Statement

Last quarter (Q4 2025), Vor Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Vor Biopharma's net income was $1.72B. See Vor Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ -3.49M$ -8.96M$ 0.00
Operating Expenses
$ 371.64M$ 121.19M$ 122.54M$ 84.46M$ 69.02M
Depreciation and Amortization
$ 2.89M$ 3.53M$ 3.49M$ 8.96M$ 1.43M
EBITDA
$ -368.75M$ -117.66M$ -114.37M$ -83.13M$ -67.58M
Operating Income
$ -371.64M$ -121.19M$ -126.04M$ -93.42M$ -69.02M
Other Income/Expenses
$ -324.34M$ 4.27M$ 8.17M$ 1.32M$ 119.00K
Pretax Income
$ -695.98M$ -116.91M$ -117.86M$ -92.09M$ -68.90M
Net Income
$ -695.98M$ -116.91M$ -117.86M$ -92.09M$ -68.90M
Per Share Metrics
Basic EPS
$ -70.50$ -34.00$ -35.00$ -46.60$ -37.80
Diluted EPS
$ -70.50$ -34.00$ -35.00$ -46.60$ -37.80
Weighted Average Shares Outstanding
 9.87M 3.44M 3.36M 1.98M 1.86M
Weighted Average Shares Outstanding (Diluted)
 9.87M 3.44M 3.36M 1.98M 1.86M
Currency in USD

Vor Biopharma Earnings and Revenue History